Tammie L. Volkman

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

LaTonya J. Hickson, Larissa Prata, Shane A. Bobart et al. · EBioMedicine · 2019 · 1.2K citations · Full text

Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism

Sundeep Khosla, Matthew T. Drake, Tammie L. Volkman et al. · Journal of Clinical Investigation · 2018 · 112 citations · Full text

Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus

Parinya Samakkarnthai, Jad Sfeir, Elizabeth J. Atkinson et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 75 citations · Full text

Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial

Joshua N. Farr, Elizabeth J. Atkinson, Sara J. Achenbach et al. · Nature Medicine · 2024 · 67 citations · Full text

Bone Disease, Bone Health, Intermittent Senolytic Therapy +7

Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes

Katherine O’Grady, Sundeep Khosla, Joshua N. Farr et al. · The Journal of Applied Laboratory Medicine · 2020 · 16 citations · Full text